20 Million Babies, One AI IVF Lab

IVF began as a Nobel Prize-winning breakthrough. Today it remains stubbornly expensive and inconsistent—limited by hundreds of manual lab steps that create variability between embryologists and restrict access worldwide. This session explores how re-engineering the IVF lab with automation, AI precision, and cell-therapy manufacturing principles can dramatically improve outcomes while reducing cost and variability. Drawing on real-world clinical data and pilot results, we'll show how fertility treatment can evolve from artisanal craft to modern medical infrastructure—unlocking a future where building families is consistent, scalable, and accessible to everyone who needs it.